Early bird registration is open and closes May 2025. Register now
Hanmi Pharmaceutical, founded in 1973 by pharmacist Lim Sung-ki, is a leading R&D driven biopharmaceutical company in Korea. Guided by the principles of “Respect for Humanity” and “Value Creation,” Hanmi is committed to advancing innovation based on its founder’s conviction to develop better medicines through proprietary technology.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
